Skip to main content

Advertisement

Log in

Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Purpose

Childhood cancer survivors are at risk for late effects which may be managed pharmacologically. The purposes of this study were to estimate and compare the prevalence of psychoactive medication use of adult survivors of childhood cancer and sibling controls, identify predictors of medication use in survivors, and investigate associations between psychoactive medications and health-related quality of life (HRQOL).

Methods

Psychoactive medication use from 1994 to 2010 was evaluated in 10,378 adult survivors from the Childhood Cancer Survivor Study. A randomly selected subset of 3,206 siblings served as a comparison group. Multivariable logistic regression models were used to calculate odds ratios (OR) for baseline and new onset of self-reported psychoactive medication use and HRQOL.

Results

Survivors were significantly more likely to report baseline (22 vs. 15 %, p < 0.001) and new onset (31 vs. 25 %, p < 0.001) psychoactive medication use compared to siblings, as well as use of multiple medications (p < 0.001). In multivariable models, controlling for pain and psychological distress, female survivors were significantly more likely to report baseline and new onset use of antidepressants (OR = 2.66, 95 % CI = 2.01–3.52; OR = 2.02, 95 % CI = 1.72–2.38, respectively) and multiple medications (OR = 1.80, 95 % CI = 1.48–2.19; OR = 1.77, 95 % CI = 1.48–2.13, respectively). Non-cranial radiation and amputation predicted incident use of analgesics >15 years following diagnosis. Antidepressants were associated with impairment across all domains of HRQOL, with the exception of physical function.

Conclusions

Prevalence of psychoactive medication use was higher among survivors for most medication classes, as was the use of multiple medications. Clinicians should be aware of the possible contribution of psychoactive medications to HRQOL.

Implications for Cancer Survivors

Survivors of childhood cancer are more likely to be prescribed psychoactive medication than their sibling counterparts, though use of such medication does not appear to normalize quality of life. Survivors are encouraged to consider additional interventions, including psychosocial support and physical exercise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W. SEER cancer statistics review, 1975–2008. Bethesda: National Cancer Institute; 2011.

    Google Scholar 

  2. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.

    Article  PubMed  CAS  Google Scholar 

  3. Greenberg DB, Goorin A, Gebhardt MC, Gupta L, Stier N, Harmon D, et al. Quality of life in osteosarcoma survivors. Oncology (Williston Park). 1994;8:19–25.

    CAS  Google Scholar 

  4. Lu Q, Krull KR, Leisenring W, Owen JE, Kawashima T, Tsao JC, et al. Pain in long-term adult survivors of childhood cancers and their siblings: a report from the Childhood Cancer Survivor Study. Pain. 2011;152:2616–24.

    Article  PubMed  Google Scholar 

  5. Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:5277–82.

    Article  PubMed  Google Scholar 

  6. Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol. 2003;21:3255–61.

    Article  PubMed  Google Scholar 

  7. Zeltzer LK, Lu Q, Leisenring W, Tsao JC, Recklitis C, Armstrong G, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2008;17:435–46.

    Article  PubMed  Google Scholar 

  8. Stuber ML, Meeske KA, Krull KR, Leisenring W, Stratton K, Kazak AE, et al. Prevalence and predictors of posttraumatic stress disorder in adult survivors of childhood cancer. Pediatrics. 2010;125:e1124–34.

    Article  PubMed  Google Scholar 

  9. Skevington SM, Wright A. Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry. 2001;178:261–7.

    Article  PubMed  CAS  Google Scholar 

  10. Allgulander C, Jorgensen T, Wade A, Francois C, Despiegel N, Auquier P, et al. Health-related quality of life (HRQOL) among patients with generalised anxiety disorder: evaluation conducted alongside an escitalopram relapse prevention trial. Curr Med Res Opin. 2007;23:2543–9.

    Article  PubMed  CAS  Google Scholar 

  11. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology. 2003;60(9):1483–8.

    Article  PubMed  CAS  Google Scholar 

  12. Meador KJ, Loring DW, Vahle VJ, Ray PG, Werz MA, Fessler AJ, et al. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology. 2005;64(12):2108–14.

    Article  PubMed  CAS  Google Scholar 

  13. Meador KJ, Loring DW, Ray PG, Murro AM, King DW, Perrine KR, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology. 2001;56(9):1177–82.

    Article  PubMed  CAS  Google Scholar 

  14. Reddick WE, Laningham FH, Glass JO, Pui CH. Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia. Neuroradiology. 2007;49(11):889–904. doi:10.1007/s00234-007-0262-9.

    Article  PubMed  Google Scholar 

  15. Porto L, Preibisch C, Hattingen E, Bartels M, Lehrnbecher T, Dewitz R, et al. Voxel-based morphometry and diffusion-tensor MR imaging of the brain in long-term survivors of childhood leukemia. Eur Radiol. 2008;18(11):2691–700. doi:10.1007/s00330-008-1038-2.

    Article  PubMed  CAS  Google Scholar 

  16. Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg. 2006;104:103–7.

    PubMed  Google Scholar 

  17. Leisenring WM, Mertens AC, Armstrong GT, Stovall MA, Neglia JP, Lanctot JQ, et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2319–27.

    Article  PubMed  Google Scholar 

  18. Robison LL, Armstrong GT, Boice JD, Chow EJ, Davies SM, Donaldson SS, et al. The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol. 2009;27:2308–18.

    Article  PubMed  Google Scholar 

  19. American Society of Health-System Pharmacists. AHFS Drug Information. 2011. http://www.ahfsdruginformation.com/. Accessed 10 June 2011.

  20. McHorney CA, Ware Jr JE, Rogers W, Raczek AE, Lu JF. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 1992;30:MS253–65.

    Article  PubMed  CAS  Google Scholar 

  21. Krull KR, Annett RD, Pan Z, Ness KK, Nathan PC, Srivastava DK, et al. Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2011;47:1380–8.

    Article  PubMed  Google Scholar 

  22. Derogatis L. Brief Symptom Inventory (BSI): administration, scoring, and procedures manual. Minneapolis: NCS Pearson; 2000.

    Google Scholar 

  23. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.

    Google Scholar 

  24. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848–56.

    Article  PubMed  Google Scholar 

  25. Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS Data Brief. 2010;(42):1–8.

  26. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry. 1998;155(1):12–21.

    PubMed  CAS  Google Scholar 

  27. van der Pal HJ, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van den Bos C, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010;170:1247–55.

    Article  PubMed  Google Scholar 

  28. Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010;174:840–50.

    Article  PubMed  CAS  Google Scholar 

  29. Brouwer CA, Postma A, Vonk JM, Zwart N, van den Berg MP, Bink-Boelkens MT, et al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. Eur J Cancer. 2011;47:2453–62.

    Article  PubMed  Google Scholar 

  30. Burton AW, Fanciullo GJ, Beasley RD, Fisch MJ. Chronic pain in the cancer survivor: a new frontier. Pain Med. 2007;8:189–98.

    Article  PubMed  Google Scholar 

  31. Nagarajan R, Kamruzzaman A, Ness KK, Marchese VG, Sklar C, Mertens A, et al. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Childhood Cancer Survivor Study. Cancer. 2011;117:625–34.

    Article  PubMed  Google Scholar 

  32. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive morbidity in the general population. Arch Gen Psychiatry. 2003;60:39–47.

    Article  PubMed  Google Scholar 

  33. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–45.

    Article  PubMed  Google Scholar 

  34. McCloughen A, Foster K. Weight gain associated with taking psychotropic medication: an integrative review. Int J Ment Health Nurs. 2011;20:202–22.

    Article  PubMed  Google Scholar 

  35. Serretti A, Chiesa A. Sexual side effects of pharmacological treatment of psychiatric diseases. Clin Pharmacol Ther. 2011;89:142–7.

    Article  PubMed  CAS  Google Scholar 

  36. Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J. Topiramate dose effects on cognition: a randomized double-blind study. Neurology. 2011;76:131–7.

    Article  PubMed  CAS  Google Scholar 

  37. Elliott TE, Renier CM, Palcher JA. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med. 2003;4:331–9.

    Article  PubMed  Google Scholar 

  38. Kobau R, Zahran H, Grant D, Thurman DJ, Price PH, Zack MM. Prevalence of active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003. Epilepsia. 2007;48:1904–13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tara M. Brinkman.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 56 kb)

ESM 2

(DOC 32 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brinkman, T.M., Ullrich, N.J., Zhang, N. et al. Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Cancer Surviv 7, 104–114 (2013). https://doi.org/10.1007/s11764-012-0250-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-012-0250-x

Keywords

Navigation